Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • October 1992 (Revised November 1997)
  • Case
  • HBS Case Collection

ImmuLogic Pharmaceutical Corporation (A): March 1991

By: Josh Lerner
  • Format:Print
  • | Pages:20
ShareBar

Abstract

ImmuLogic Pharmaceutical Corp., a development-stage biotechnology company, is considering making an initial offering of common stock. The diverse perspectives of the entrepreneur, venture capitalist, investment banker, and institutional investor are explored. Problems of valuation are highlighted. The challenges posed by "windows" for public offerings are considered.

Keywords

Decisions; Entrepreneurship; Venture Capital; Banks and Banking; Initial Public Offering; Going Public; Perspective; Valuation; Biotechnology Industry; Pharmaceutical Industry

Citation

Lerner, Josh. "ImmuLogic Pharmaceutical Corporation (A): March 1991." Harvard Business School Case 293-066, October 1992. (Revised November 1997.)
  • Educators
  • Purchase

About The Author

Josh Lerner

Entrepreneurial Management
→More Publications

More from the Author

    • 2023
    • Faculty Research

    Learning by Investing: Entrepreneurial Spillovers from Venture Capital

    By: Josh Lerner, Jinlin Li and Tong Liu
    • August 2023
    • Management Science

    Anti-Corruption, Government Subsidies, and Innovation: Evidence from China

    By: Lily Fang, Josh Lerner, Chaopeng Wu and Qi Zhang
    • July 2023
    • Journal of Portfolio Management

    Takahashi-Alexander Revisited: Modeling Private Equity Portfolio Outcomes Using Historical Simulations

    By: Dawson Beutler, Alex Billias, Sam Holt, Josh Lerner and TzuHwan Seet
More from the Author
  • Learning by Investing: Entrepreneurial Spillovers from Venture Capital By: Josh Lerner, Jinlin Li and Tong Liu
  • Anti-Corruption, Government Subsidies, and Innovation: Evidence from China By: Lily Fang, Josh Lerner, Chaopeng Wu and Qi Zhang
  • Takahashi-Alexander Revisited: Modeling Private Equity Portfolio Outcomes Using Historical Simulations By: Dawson Beutler, Alex Billias, Sam Holt, Josh Lerner and TzuHwan Seet
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College